Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC101927137 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DAG1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
OARD1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
FBXL22 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors
CLN8 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CD79B - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
LSAMP - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Profile neighbors
CEP85 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GUCA2B - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
LITAF - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
EIF1B - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SEPW1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
DYRK2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GRIK4 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
EXOC6B - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CLCN7 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CCNY - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SRGAP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on